SCHEMBL7944158

SCHEMBL7944158

O=C1c2ccccc2C(=O)N1CCc1ccc(OC(F)(F)F)c(OC(F)(F)F)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.52
ALDH1A1 P00352 2/20 0.50
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
KMT2A Q03164 1/20 0.48
CASP3 P42574 1/20 0.48
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA4 P22748 1/20 0.47
CA9 Q16790 1/20 0.47
NR1H2 P55055 1/20 0.43
NR1H3 Q13133 1/20 0.43
RAB9A P51151 2/20 0.43
KDM4E B2RXH2 1/20 0.43
GAA P10253 1/20 0.43
MAPT P10636 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
KCNJ1 P48048 1/20 0.42
KCNH2 Q12809 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7952730 0.82 CASP3 (0.55) ALDH1A1CASP3CA1CA2CA4
SCHEMBL8777049 0.79 LMNA (0.72) LMNAALDH1A1NR1H2NR1H3KDM4E
SCHEMBL476943 0.77 KMT2A (0.76) LMNAALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL2445257 0.76 TDP1 (0.51) KMT2ACASP3MAPTSMN1; SMN2TDP1
SCHEMBL7957008 0.74 ADRA1D (0.62) ALDH1A1KMT2ACASP3CA1CA2
SCHEMBL7956763 0.73 CASP3 (0.55) LMNAALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL3193194 0.73 LMNA (0.57) LMNAALDH1A1KMT2ACASP3CA1
SCHEMBL27721810 0.72 MMP2 (0.43) LMNAALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL7954280 0.71 CASP3 (0.65) LMNAALDH1A1CASP3CA1CA2
SCHEMBL11743353 0.71 ALDH1A1 (0.69) LMNAALDH1A1NR1H2NR1H3RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6232475-B1 REACTING A SUBSTITUTED BROMOBENZENE WITH N-VINYLIMIDE; CATALYTIC HYDROGENATION BAYER AKTIENGESELLSCHAFT (DE) 2001-05-15 US disclosed
EP-1013637-A2 Process for the preparation of fluor containing phenethylamines and fluor containing beta-iminovinyl- and beta-iminoethylphenyl compounds Bayer Aktiengesellschaft (DE) 2000-06-28 EP disclosed